Table of Contents Table of Contents
Previous Page  36 / 54 Next Page
Information
Show Menu
Previous Page 36 / 54 Next Page
Page Background

PANITUMUMAB – 1ª LÍNEA

(87%)

Boeckx N, et al. Ann Oncol 2017